Carles Iniesta-Navalón (Carles Iniesta Navalón)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

Ciencia & saude coletiva

European journal of hospital pharmacy : science and practice

Hospital Universitario Reina Sofia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario Reina Sofia Mar 05 1979

Spain

FEA Farmacia Hospitalaria :: Servicio de Farmacia

Publications

Rebeca Añez-Castaño, Carles Iniesta-Navalón, Miguel Almanchel-Rivadeneyra, Eva García-Villalba, Eva Oliver-Galera, Lorena Rentero-Redondo
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease. European journal of hospital pharmacy : science and practice (2024)
Lidia Serrano-Díaz, Carles Iniesta-Navalón, Rosa Gómez-Espín, Isabel Nicolás-de Prado, Enrique Bernal-Morell, Lorena Rentero-Redondo
Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2022)
Mayte Gil-Candel, Juan José Gascón Cánovas, Elena Urbieta Sanz, Rosa Gómez Espín, Isabel Nicolás de Prado, Carles Iniesta-Navalón
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 112 (5) (2021)
Mayte Gil-Candel, Juan José Gascón Cánovas, Rosa Gómez Espín, Isabel Nicolás de Prado, Lorena Rentero Redondo, Elena Urbieta Sanz, Carles Iniesta-Navalón
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 112 (8) (2021)
Rosa Gómez Espín, Isabel Nicolás De Prado, Mayte Gil-Candel, Marta González Carrión, Lorena Rentero Redondo, Carles Iniesta-Navalón
Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 113 (2) (2021)
Carles Iniesta-Navalón, Mayte Gil-Candel, Ignacio Salar Valverde, Isabel Nicolás de Prado, Rosa Gómez Espín, Lorena Rentero Redondo
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 113 (11) (2021)
Carles Iniesta-Navalón, Juan José Gascón-Cánovas, Zenewton André da Silva Gama, José Francisco Sánchez-Ruiz, Erick Angelico Gutiérrez-Estrada, Ernesto De-la-Cruz-Sánchez, Owen Harrington-Fernández
Potential and clinical relevant drug-drug interactions among elderly from nursing homes: a multicentre study in Murcia, Spain. Ciencia & saude coletiva 24 (5) (2019)

Carles Iniesta-Navalón.css-eqlu8i{font-size:small;padding-left:4px;} (Carles Iniesta Navalón)

Publication Activity (10 Years)

Top Topics

Top Venues

Carles Iniesta-Navalón (Carles Iniesta Navalón)